JC: Convalescent plasma in COVID 19 patients.

This month the BMJ has published a trial on the use of convalescent plasma in the treatment of admitted patients with COVID-19 (the PLACID trial). Convalescent plasma therapy basically takes plasma, together with antibodies from patients who have recovered from COVID-19 and then transfuses that into patients in the acute phase of their disease. The … Continue reading JC: Convalescent plasma in COVID 19 patients.